The following guide identifies commonly used myeloma abbreviations and acronyms. Another document, The IMF Myeloma Terms and Definitions, defines these terms, and many others, more fully. A third reference you may also find helpful, The IMF Guide to Drug Names, lists each approved and experimental myeloma drug by its number/letter code, generic name, and brand name.
What do carfilzomib and PR-171 have in common? They are the same drug! Between the original name, the generic name and the brand name, it is hard to keep myeloma drugs straight. Here's a handy guide put together by IMF Medical Editor Debbie Birns.